Clinical Trials Browser

Phase 1 × Neoplasms × LY-2157299 × Clear all

NCT02304419 2016-10-05

A Study of Galunisertib on the Immune System in Participants With Cancer

Phase 1 Completed

Neoplasms

NCT01722825 2014-07-01

Study of LY2157299 in Japanese Participants With Cancer

Phase 1 Completed

Neoplasm Metastasis, Neoplasms